Olanzapine Helps with Chemotherapy-Induced Nausea, Vomiting - NCI

$ 24.00

4.8
(226)
In stock
Description

An NCI Cancer Currents blog on a large clinical trial that showed an anti-psychotic drug can help prevent nausea and vomiting in patients receiving chemotherapy.

LCT10001280

Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting

Metagenomics and chemotherapy‐induced nausea: A roadmap for future

A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting

Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based Therapies

Should Olanzapine be Advocated Over Conventional Anti-Emetics for

A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting - ScienceDirect

Olanzapine (LY170053), 5-HT2/D1/D2 Antagonist

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting

Nausea and Vomiting and Cancer Treatment - Side Effects - NCI

Olanzapine for Prevention or Management of Chemotherapy-Induced Nausea and Vomiting: A Promising Option

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. - Abstract - Europe PMC